T Sudo

6.7k total citations · 1 hit paper
80 papers, 5.6k citations indexed

About

T Sudo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, T Sudo has authored 80 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 27 papers in Immunology and 16 papers in Oncology. Recurrent topics in T Sudo's work include Melanoma and MAPK Pathways (14 papers), Immune Cell Function and Interaction (13 papers) and NF-κB Signaling Pathways (10 papers). T Sudo is often cited by papers focused on Melanoma and MAPK Pathways (14 papers), Immune Cell Function and Interaction (13 papers) and NF-κB Signaling Pathways (10 papers). T Sudo collaborates with scholars based in Japan, United States and Poland. T Sudo's co-authors include Hiroyuki Osada, Minetaro Ogawa, Shinichi Hayashi, Takahiro Kunisada, S Nishikawa, Shunsuke Ishii, Masahito Matsumoto, Masafumi Tsujimoto, Noriko Ohno and Hiromitsu Nakauchi and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

T Sudo

80 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression and function of c-kit in hemopoietic progenitor cells.

1991 642 citations Minetaro Ogawa, S Nishikawa et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by T Sudo

Since Specialization

Citations

This map shows the geographic impact of T Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Sudo more than expected).

Fields of papers citing papers by T Sudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Sudo. The network helps show where T Sudo may publish in the future.

Co-authorship network of co-authors of T Sudo

This figure shows the co-authorship network connecting the top 25 collaborators of T Sudo. A scholar is included among the top collaborators of T Sudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Sudo. T Sudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transcriptomic Evaluation of Pulmonary Fibrosis-Related Genes: Utilization of Transgenic Mice with Modifying p38 Signal in the Lungs 2020 ·International Journal of Molecular Sciences ·Shuichi Matsuda, Jun‐Dal Kim, Fumihiro Sugiyama, (unknown), Junji Ishida, Kazuya Murata, (unknown), Kana Namiki, T Sudo, Tomoyuki Kuwaki, Masahiko Hatano, Koichiro Tatsumi, Akiyoshi Fukamizu, Yoshitoshi Kasuya	9
2	Genetic and Pharmacological Inhibition of p38α Improves Locomotor Recovery after Spinal Cord Injury 2017 ·Frontiers in Pharmacology ·(unknown), Yusuke Naito, Kensuke Tanaka, Kento Yoshioka, Kenichi Suzuki, T Sudo, Masahiko Hagihara, Masahiko Hatano, Koichiro Tatsumi, Yoshitoshi Kasuya	7
3	Mechanism for p38α-mediated Experimental Autoimmune Encephalomyelitis 2012 ·Journal of Biological Chemistry ·Kana Namiki, (unknown), Kento Yoshioka, Kensuke Tanaka, Kazuya Murata, Junji Ishida, (unknown), Jun‐Dal Kim, Naoki Tokuhara, (unknown), Motohisa Shimizu, Yukinori Wada, (unknown), (unknown), Masahiko Hagihara, Sadao Kimura, T Sudo, Akiyoshi Fukamizu, Yoshitoshi Kasuya	30
4	p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression 2005 ·Biochemical and Biophysical Research Communications ·T Sudo, (unknown), Hiroshi Matsuzaki, Hiroyuki Osada	33
5	Role of p38 Mitogen-Activated Protein Kinase in Thrombus Formation 2004 ·Journal of Receptors and Signal Transduction ·Kanako Sakurai, (unknown), T Sudo, Yoh Takuwa, Sadao Kimura, Yoshitoshi Kasuya	29
6	Essential Role of p38 Mitogen-activated Protein Kinase in Contact Hypersensitivity 2002 ·Journal of Biological Chemistry ·(unknown), Shinya Amano, Sadao Kimura, Sachie Asada, Atsushi Utani, (unknown), Hiroyuki Osada, Hajime Tsunoda, Yoko Irukayama‐Tomobe, Katsutoshi Goto, Michael Karin, T Sudo, Yoshitoshi Kasuya	49
7	Exip, a New Alternative Splicing Variant of p38α, Can Induce an Earlier Onset of Apoptosis in HeLa Cells 2002 ·Biochemical and Biophysical Research Communications ·T Sudo, Yuki Yagasaki, Hiroshi Hama, Naoko Watanabe, Hiroyuki Osada	22
8	Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells 2001 ·The EMBO Journal ·T Sudo	118
9	Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL) 2000 ·Journal of Biological Chemistry ·Masahito Matsumoto, T Sudo, Tamio Saito, Hiroyuki Osada, Masafumi Tsujimoto	459
10	Requirement for p38α in Erythropoietin Expression 2000 ·Cell ·Kumiko Tamura, T Sudo, Uwe Senftleben, Agnes Dadak, Randall S. Johnson, Michael Karin	295
11	p62 Functions as a p38 MAP Kinase Regulator 2000 ·Biochemical and Biophysical Research Communications ·T Sudo, (unknown), Hiroyuki Osada	39
12	Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. 1995 ·PubMed ·T Sudo, Shimpei Nishikawa, Minetaro Ogawa, Hiroshi Kataoka, Noriko Ohno, Akiko Izawa, Seiji Hayashi	150
13	RK‐682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G₁phase 1995 ·FEBS Letters ·(unknown), T Sudo, Hiroyuki Osada	128
14	RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. 1995 ·The Journal of Immunology ·Kensuke Miyake, Yoshio Yamashita, M Ogata, T Sudo, Masao Kimoto	172
15	Mapping of the human gene for the human immunodeficiency virus type 1 enhancer binding protein HIV-EP2 to chromosome 6q23–q24 1992 ·Genomics ·T Sudo, Kazuo Ozawa, Eiichi Soeda, Nobuo Nomura, (unknown)	5
16	Assignment of the human CREB2 (CRE-BP1) gene to 2q32 1991 ·Genomics ·Kazuo Ozawa, T Sudo, Eiichi Soeda, (unknown), Shunsuke Ishii	14
17	Stepwise progression of B lineage differentiation supported by interleukin 7 and other stromal cell molecules. 1990 ·The Journal of Experimental Medicine ·Shinichi Hayashi, Takahiro Kunisada, Minetaro Ogawa, T Sudo, Hiroaki Kodama, Toshio Suda, S Nishikawa	134
18	Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony. 1988 ·The Journal of Experimental Medicine ·Nagahiro Minato, Masakazu Hattori, T Sudo, Shogo Kano, Yoshiaki Miura, J Suda, Toshio Suda	15
19	Generation of continuous large granular lymphocyte lines by interleukin 2 from the spleen cells of mice infected with Moloney leukemia virus. Involvement of interleukin 3. 1987 ·The Journal of Experimental Medicine ·Masakazu Hattori, T Sudo, M Iizuka, S Kobayashi, Shin‐ichi Nishio, Shogo Kano, Nagahiro Minato	19
20	A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells. 1986 ·The Journal of Experimental Medicine ·Sachiko Kajigaya, Toshio Suda, J Suda, Masaki Saito, Yoshiaki Miura, M Iizuka, Shigeyasu Kobayashi, Nagahiro Minato, T Sudo	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact